{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:23:47Z","timestamp":1790191427286,"version":"4.1.0"},"reference-count":33,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"5","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO"],"published-print":{"date-parts":[[2024,2,10]]},"abstract":"<jats:sec>\n                    <jats:title>PURPOSE<\/jats:title>\n                    <jats:p>Standard therapy for locally advanced non\u2013small-cell lung cancer (LA-NSCLC) is concurrent chemoradiotherapy followed by adjuvant durvalumab. For biomarker-selected patients with LA-NSCLC, we hypothesized that sequential pembrolizumab and risk-adapted radiotherapy, without chemotherapy, would be well-tolerated and effective.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>Patients with stage III NSCLC or unresectable stage II NSCLC and an Eastern Cooperative Oncology Group performance status of 0-1 were eligible for this trial. Patients with a PD-L1 tumor proportion score (TPS) of \u226550% received three cycles of induction pembrolizumab (200 mg, once every 21 days), followed by a 20-fraction course of risk-adapted thoracic radiotherapy (55 Gy delivered to tumors or lymph nodes with metabolic volume exceeding 20 cc, 48 Gy delivered to smaller lesions), followed by consolidation pembrolizumab to complete a 1-year treatment course. The primary study end point was 1-year progression-free survival (PFS). Secondary end points included response rates after induction pembrolizumab, overall survival (OS), and adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Twenty-five patients with a PD-L1 TPS of \u226550% were enrolled. The median age was 71, most patients (88%) had stage IIIA or IIIB disease, and the median PD-L1 TPS was 75%. Two patients developed disease progression during induction pembrolizumab, and two patients discontinued pembrolizumab after one infusion because of immune-related adverse events. Using RECIST criteria, 12 patients (48%) exhibited a partial or complete response after induction pembrolizumab. Twenty-four patients (96%) received definitive thoracic radiotherapy. The 1-year PFS rate is 76%, satisfying our efficacy objective. One- and 2-year OS rates are 92% and 76%, respectively. The most common grade 3 adverse events were colitis (n = 2, 8%) and esophagitis (n = 2, 8%), and no higher-grade treatment-related adverse events have occurred.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>Pembrolizumab and risk-adapted radiotherapy, without chemotherapy, are a promising treatment approach for patients with LA-NSCLC with a PD-L1 TPS of \u226550%.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/jco.23.00627","type":"journal-article","created":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T16:02:19Z","timestamp":1700582539000},"page":"562-570","update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":60,"title":["Selective Personalized RadioImmunotherapy for Locally Advanced Non\u2013Small-Cell Lung Cancer Trial (SPRINT)"],"prefix":"10.1200","volume":"42","clinical-trial-number":[{"clinical-trial-number":"nct03523702","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9593-513X","authenticated-orcid":false,"given":"Nitin","family":"Ohri","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Montefiore Einstein Comprehensive Cancer Center, Bronx, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8174-5199","authenticated-orcid":false,"given":"Shruti","family":"Jolly","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin T.","family":"Cooper","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Perlmutter Cancer Center, New York University Grossman School of Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7835-718X","authenticated-orcid":false,"given":"Rafi","family":"Kabarriti","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Montefiore Einstein Comprehensive Cancer Center, Bronx, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Bodner","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Montefiore Einstein Comprehensive Cancer Center, Bronx, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6996-3572","authenticated-orcid":false,"given":"Jonathan","family":"Klein","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Montefiore Einstein Comprehensive Cancer Center, Bronx, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandan","family":"Guha","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Montefiore Einstein Comprehensive Cancer Center, Bronx, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3349-9090","authenticated-orcid":false,"given":"Shankar","family":"Viswanathan","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Population Health, Montefiore Einstein Comprehensive Cancer Center, Bronx, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0390-5716","authenticated-orcid":false,"given":"Elaine","family":"Shum","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Medicine, Perlmutter Cancer Center, New York University Grossman School of Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1556-1543","authenticated-orcid":false,"given":"Joshua K.","family":"Sabari","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Medicine, Perlmutter Cancer Center, New York University Grossman School of Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6051-2732","authenticated-orcid":false,"given":"Haiying","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Oncology, Montefiore Einstein Comprehensive Cancer Center, Bronx, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasim A.","family":"Gucalp","sequence":"additional","affiliation":[{"name":"Department of Oncology, Montefiore Einstein Comprehensive Cancer Center, Bronx, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Castellucci","sequence":"additional","affiliation":[{"name":"Department of Oncology, Montefiore Einstein Comprehensive Cancer Center, Bronx, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0339-3087","authenticated-orcid":false,"given":"Angel","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Hematology-Oncology, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5240-3811","authenticated-orcid":false,"given":"Shirish M.","family":"Gadgeel","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Henry Ford Cancer Institute, Henry Ford Health System, Detroit, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7548-8360","authenticated-orcid":false,"given":"Balazs","family":"Halmos","sequence":"additional","affiliation":[{"name":"Department of Oncology, Montefiore Einstein Comprehensive Cancer Center, Bronx, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"b1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.2543"},{"key":"b2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1809697"},{"key":"b3","doi-asserted-by":"publisher","DOI":"10.1126\/science.aax0182"},{"key":"b4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01162"},{"key":"b5","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2019.11.015"},{"key":"b6","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2021.08.019"},{"key":"b7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14030614"},{"key":"b8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2020.11.002"},{"key":"b9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606774"},{"key":"b10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2010.12.055"},{"key":"b11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2016.10.031"},{"key":"b12","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-020-01546-y"},{"key":"b13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2017.10.032"},{"key":"b14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026"},{"key":"b15","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.108.057307"},{"key":"b16","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01162"},{"key":"b17","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djg052"},{"key":"b18","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2020.09.010"},{"key":"b19","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00228-2"},{"key":"b20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1917346"},{"key":"b21","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.08.039"},{"key":"b22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2013.07.029"},{"key":"b23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2012.04.043"},{"key":"b24","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.6332"},{"key":"b25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2014.04.025"},{"key":"b26","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2020.05.051"},{"key":"b27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.311.7010.899"},{"key":"b28","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djr325"},{"key":"b29","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.16_suppl.8513"},{"key":"b30","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S336262"},{"key":"b31","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-016-0640-8"},{"key":"b32","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00227"},{"key":"b33","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn559"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.23.00627","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T18:01:08Z","timestamp":1707328868000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.23.00627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,10]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,2,10]]}},"alternative-id":["10.1200\/JCO.23.00627"],"URL":"https:\/\/doi.org\/10.1200\/jco.23.00627","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,10]]},"assertion":[{"value":"2023-03-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-25","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}